Saqib Islam - 27 Feb 2025 Form 4 Insider Report for SpringWorks Therapeutics, Inc. (SWTX)

Signature
/s/ Francis I. Perier, Jr. as Attorney-in Fact
Issuer symbol
SWTX
Transactions as of
27 Feb 2025
Net transactions value
-$4,300,334
Form type
4
Filing time
05 Mar 2025, 18:32:29 UTC
Previous filing
24 Feb 2025
Next filing
30 May 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SWTX Common Stock Tax liability $1,642,678 -30,756 -3% $53.41 1,003,869 27 Feb 2025 Direct
transaction SWTX Common Stock Sale $625,016 -11,800 -1.2% $52.97 992,069 03 Mar 2025 Direct F1, F2
transaction SWTX Common Stock Sale $1,280,135 -23,600 -2.4% $54.24 968,469 03 Mar 2025 Direct F1, F3
transaction SWTX Common Stock Sale $639,783 -11,600 -1.2% $55.15 956,869 03 Mar 2025 Direct F1, F4
transaction SWTX Common Stock Sale $78,588 -1,400 -0.15% $56.13 955,469 03 Mar 2025 Direct F1, F5
transaction SWTX Common Stock Sale $34,134 -600 -0.06% $56.89 954,869 03 Mar 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a trading plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, adopted on February 29, 2024.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.70 to $53.64. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F3 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.70 to $54.685. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F4 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.70 to $55.68. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F5 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.84 to $56.36. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.